CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma

Background CDCA7 is a copy number amplified gene identified not only in esophageal squamous cell carcinoma (ESCC) but also in various cancer types. Its clinical relevance and underlying mechanisms in ESCC have remained unknown. Methods Tissue microarray data was used to analyze its expression in 179 ESCC samples. The effects of CDCA7 on proliferation, colony formation, and cell cycle were tested in ESCC cells. Real-time PCR and Western blot were used to detect the expression of its target genes. Correlation of CDCA7 with its target genes in ESCC and various SCC types was analyzed using GSE53625 and TCGA data. The mechanism of CDCA7 was studied by chromatin immunoprecipitation (ChIP), luciferase reporter assays, and rescue assay. Results The overexpression of CDCA7 promoted proliferation, colony formation, and cell cycle in ESCC cells. CDCA7 affected the expression of cyclins in different cell phases. GSE53625 and TCGA data showed CCNA2 expression was positively correlated with CDCA7. The knockdown of CCNA2 reversed the malignant phenotype induced by CDCA7 overexpression. Furthermore, CDCA7 was found to directly bind to CCNA2, thus promoting its expression. Conclusions Our results reveal a novel mechanism of CDCA7 that it may act as an oncogene by directly upregulating CCNA2 to facilitate tumor progression in ESCC.

[1]  S. Ray,et al.  Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass , 2020, Journal of translational medicine.

[2]  C. Liao,et al.  High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer , 2020, Molecular medicine reports.

[3]  Hongying Wang,et al.  CDCA7 promotes lung adenocarcinoma proliferation via regulating the cell cycle. , 2019, Pathology, research and practice.

[4]  T. Iglesias,et al.  CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion , 2019, Haematologica.

[5]  L. Fournel,et al.  Interconnection between Metabolism and Cell Cycle in Cancer. , 2019, Trends in biochemical sciences.

[6]  Yue Li,et al.  Overexpression of CDCA7 predicts poor prognosis and induces EZH2‐mediated progression of triple‐negative breast cancer , 2018, International journal of cancer.

[7]  J. Redondo,et al.  CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth , 2018, Haematologica.

[8]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[9]  H. Aburatani,et al.  Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. , 2016, Gastroenterology.

[10]  Jing Liu,et al.  Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma , 2016, American journal of human genetics.

[11]  Joanna Kalucka,et al.  Metabolic control of the cell cycle , 2015, Cell cycle.

[12]  D. Peeper,et al.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis , 2015, Cell cycle.

[13]  Huanming Yang,et al.  Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma , 2015, American journal of human genetics.

[14]  Jian Sun,et al.  Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[15]  M. Malumbres,et al.  Cyclin-dependent kinases , 2014, Genome Biology.

[16]  Qiang Feng,et al.  Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.

[17]  Li Shang,et al.  Genomic and molecular characterization of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[18]  Fang Zhou,et al.  LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma , 2014, Gut.

[19]  N. Turner,et al.  Tumour selective targeting of cell cycle kinases for cancer treatment. , 2013, Current opinion in pharmacology.

[20]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[21]  Amber L. Couzens,et al.  The MYC-Associated Protein CDCA7 Is Phosphorylated by AKT To Regulate MYC-Dependent Apoptosis and Transformation , 2012, Molecular and Cellular Biology.

[22]  Salvador Moncada,et al.  Fulfilling the metabolic requirements for cell proliferation. , 2012, The Biochemical journal.

[23]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[24]  D. Wolgemuth.  Function of the A-type cyclins during gametogenesis and early embryogenesis. , 2011, Results and problems in cell differentiation.

[25]  D. Fisher.  Control of DNA replication by cyclin-dependent kinases in development. , 2011, Results and problems in cell differentiation.

[26]  James M. Roberts,et al.  Cyclin A Promotes S-Phase Entry via Interaction with the Replication Licensing Factor Mcm7 , 2010, Molecular and Cellular Biology.

[27]  Shunichi Takeda,et al.  Cyclin-dependent kinases and cell-cycle transitions: does one fit all? , 2008, Nature Reviews Molecular Cell Biology.

[28]  Kenichi Yoshida,et al.  JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. , 2006, Biochimica et biophysica acta.

[29]  C. Dang,et al.  The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. , 2005, Cancer research.

[30]  Chi V. Dang,et al.  A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Poon,et al.  Cyclin A in cell cycle control and cancer , 2002, Cellular and Molecular Life Sciences CMLS.

[32]  J. Pines,et al.  Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. , 2002, Molecular biology of the cell.

[33]  Massimo Pandolfo,et al.  Molecular Basis , 2022 .

[34]  C. Dang,et al.  A Novel c-Myc-responsive Gene, JPO1, Participates in Neoplastic Transformation* , 2001, The Journal of Biological Chemistry.

[35]  J. Nesland,et al.  Over‐expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomas , 2001, International journal of cancer.

[36]  J. Pines,et al.  Cyclin a Is Destroyed in Prometaphase and Can Delay Chromosome Alignment and Anaphase , 2001, The Journal of cell biology.

[37]  T. Tsuji,et al.  Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas. , 2001, Anticancer research.

[38]  E Bengtsson,et al.  A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. , 2000, Experimental cell research.

[39]  J. Pines,et al.  Human Cyclin a Is Required for Mitosis until Mid Prophase , 1999, The Journal of cell biology.

[40]  T. Nikaido,et al.  Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin‐dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix , 1998, Cancer.

[41]  C. Dang,et al.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene , 1997, Molecular and cellular biology.

[42]  M. Volm,et al.  Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. , 1997, British Journal of Cancer.

[43]  D. Wolgemuth,et al.  The developmentally restricted pattern of expression in the male germ line of a murine cyclin A, cyclin A2, suggests roles in both mitotic and meiotic cell cycles. , 1996, Developmental biology.

[44]  L. Hengst,et al.  Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1 , 1995, Molecular and cellular biology.

[45]  C. Prives,et al.  Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.

[46]  H. Leonhardt,et al.  Reversal of terminal differentiation and control of DNA replication: Cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication , 1993, Cell.

[47]  R. Pepperkok,et al.  Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[48]  D. Fesquet,et al.  Cyclin A is required in S phase in normal epithelial cells. , 1992, Biochemical and biophysical research communications.

[49]  U. Strausfeld,et al.  Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.

[50]  Tony Hunter,et al.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B , 1990, Nature.

[51]  C. Bréchot,et al.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.

[52]  J. Ruderman,et al.  The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes , 1986, Cell.